Gala 2021

It's That Time of Year!

Check out the details and let us know you can join us by registering.
homepage horizontal active

Magician Alan Hudson Headlines Action Awards Virtual Celebration

Alan Hudson's Virtual Magic Show advertisement

For our annual Action Awards Celebration, the Allergy Advocacy Association is delighted to present magician and comedian Alan Hudson, our special guest entertainer on our ZOOM broadcast Wednesday, Oct. 20, 7pm.... Read the article here.

E-Greetings from the Allergy Advocacy Association, May 2016

There’s certainly strength in numbers, and the Allergy Advocacy Association was in full force with our friends from the Food Allergy and Research Education group at our recent Allergy Awareness event in Albany. We are hopeful the legislation that would allow public venues to stock epinephrine will be passed by the New York State Assembly before their legislative session ends in mid-June, as it has already been passed by the State Senate. If you would like to help in our efforts, please sign our online petition at or send a quick email or letter to your State Assembly representative. Together we can make a real difference in saving lives!

Now is also the perfect time to start checking out summer camps for your children. Be sure to inquire about safety procedures when it comes to stocking and administering epinephrine. Keep in mind that 50% of all fatal reactions to insect venom occur with no previous history of life-threatening allergic reactions. Not only should epi-pens be stocked on site, they need to be taken along when going on field trips, hiking in the woods, or any other activities away from camp headquarters. Our Association has donated epi-pens in the past to the Boy and Girl Scout Associations for just such a purpose.

Enjoy the spring weather whenever it arrives!

Parents Press for More Available Allergy Antidote

A3 & FARE Team Up at Albany Allergy Awareness Event

Jon Terry Speaks In Albany May 4, 2016
Jon Terry, founder of the Allergy Advocacy Association based in Brockport, Monroe County, speaks at a news conference in Albany on May 4, 2016 (Photo: Nick Muscavage, Albany Bureau)

We received a lot of nice publicity from our recent Allergy Awareness event in Albany. Our founder, Jon Terry, spoke at a press conference and an article was published in the Democrat and Chronicle. Many thanks go to all who participated including the Food Allergy and Research Education (FARE) group, including the parents and children who have experienced tragic loss or face daily challenges due to severe food allergies.

Continue Reading

New York State EMS Moves Ahead to Reduce Costs

UPDATE: SEK Check & Inject Program

Dr. Jeremy Cushman
Dr. Jeremy Cushman

We are pleased to report that much progress has been made in regard to New York’s Check and Inject Program, originally known as the “Syringe Epinephrine Kit Program.” Eighteen Emergency Medical Services (EMS) Councils are now participating, enabling thousands of emergency medical technicians (EMTs) to administer epinephrine with a special syringe instead of the more expensive epinephrine auto injectors. Previously, only EMTs with advanced training (Advanced EMT’s or Paramedics) could use the syringes. Once the pilot program is completed by the end of the year, there should be sufficient data for the State Emergency Medical Advisory Committee to make a recommendation to the State Health Commissioner to further expand the program. You can read the full article here.

Continue Reading

Nanoparticle Shuts Off Allergic Reaction to Allergens

New Therapy for Asthma and Allergies Looks Promising

Logo of Northwestern University Fineberg School Of Medicine

Could nanoparticles be the solution to preventing an allergic reaction or asthma attack? Researchers at Northwestern University are getting positive results using very small particles composed of an FDA-approved biopolymer called PLGA that includes lactic acid and glycolic acid. When an allergen-loaded nanoparticle was injected into the bloodstream of mice, the immune system wasn't concerned with it because it saw the particle as innocuous debris and an attack was avoided. Clinical trials in humans will begin soon.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions